654 related articles for article (PubMed ID: 33931473)
1. Overlap of immunotherapy-related pneumonitis and COVID-19 pneumonia: diagnostic and vaccine considerations.
Abid MB
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33931473
[TBL] [Abstract][Full Text] [Related]
2. The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't.
Malek AE; Cornejo PP; Daoud N; Alam M
Immunotherapy; 2022 Feb; 14(2):91-94. PubMed ID: 34747190
[No Abstract] [Full Text] [Related]
3. Indications for and contraindications of immune checkpoint inhibitors in cancer patients with COVID-19 vaccination.
Luo B; Li J; Hou X; Yang Q; Zhou Y; Ye J; Wu X; Feng Y; Hu T; Xu Z; He Y; Sun J
Future Oncol; 2021 Sep; 17(26):3477-3484. PubMed ID: 34189948
[TBL] [Abstract][Full Text] [Related]
4. Case Report: Clinical Management of a Patient With Metastatic Non-Small Cell Lung Cancer Newly Receiving Immune Checkpoint Inhibition During Symptomatic COVID-19.
Mellinghoff SC; Vanshylla K; Dahlke C; Addo MM; Cornely OA; Klein F; Persigehl T; Rybniker J; Gruell H; Bröckelmann PJ
Front Immunol; 2021; 12():798276. PubMed ID: 34987520
[TBL] [Abstract][Full Text] [Related]
5. Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment.
Rossi E; Schinzari G; Tortora G
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32699182
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 lung injury as a primer for immune checkpoint inhibitors (ICIs)-related pneumonia in a patient affected by squamous head and neck carcinoma treated with PD-L1 blockade: a case report.
Dipasquale A; Persico P; Lorenzi E; Rahal D; Santoro A; Simonelli M
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33574054
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cell vaccine immunotherapy; the beginning of the end of cancer and COVID-19. A hypothesis.
Saadeldin MK; Abdel-Aziz AK; Abdellatif A
Med Hypotheses; 2021 Jan; 146():110365. PubMed ID: 33221134
[TBL] [Abstract][Full Text] [Related]
8. Repurposing CD8
Gujar S; Pol JG; Kim Y; Kroemer G
Oncoimmunology; 2020 Jul; 9(1):1794424. PubMed ID: 32923158
[TBL] [Abstract][Full Text] [Related]
9. Interstitial pneumonitis in the COVID-19 era: a difficult differential diagnosis in patients with lung cancer.
Catania C; Stati V; Spitaleri G
Tumori; 2021 Jun; 107(3):267-269. PubMed ID: 32842909
[TBL] [Abstract][Full Text] [Related]
10. Interrogation of the cellular immunome of cancer patients with regard to the COVID-19 pandemic.
Donahue RN; Marté JL; Goswami M; Toney NJ; Tsai YT; Gulley JL; Schlom J
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33707314
[TBL] [Abstract][Full Text] [Related]
11. Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection.
Yatim N; Boussier J; Tetu P; Smith N; Bruel T; Charbit B; Barnabei L; Corneau A; Da Meda L; Allayous C; Baroudjian B; Jebali M; Herms F; Grzelak L; Staropoli I; Calmettes V; Hadjadj J; Peyrony O; Cassius C; LeGoff J; Kramkimel N; Aractingi S; Fontes M; Blanc C; Rieux-Laucat F; Schwartz O; Terrier B; Duffy D; Lebbé C
Sci Adv; 2021 Aug; 7(34):. PubMed ID: 34407944
[TBL] [Abstract][Full Text] [Related]
12. Management of immune checkpoint therapy for patients with cancer in the face of COVID-19.
Shen C; Li Q; Wei Y; Li Y; Li J; Tao J
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33303577
[TBL] [Abstract][Full Text] [Related]
13. Severe acute respiratory syndrome coronavirus 2 vaccination and cancer therapy: A successful but mindful mix.
Di Giacomo AM; Giacobini G; Gandolfo C; Lofiego MF; Cusi MG; Maio M
Eur J Cancer; 2021 Oct; 156():119-121. PubMed ID: 34428684
[No Abstract] [Full Text] [Related]
14. SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: Recommendations from the French society for ImmunoTherapy of Cancer (FITC).
Gauci ML; Coutzac C; Houot R; Marabelle A; Lebbé C;
Eur J Cancer; 2021 May; 148():121-123. PubMed ID: 33743480
[No Abstract] [Full Text] [Related]
15. Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors.
Terpos E; Zagouri F; Liontos M; Sklirou AD; Koutsoukos K; Markellos C; Briasoulis A; Papanagnou ED; Trougakos IP; Dimopoulos MA
J Hematol Oncol; 2021 May; 14(1):86. PubMed ID: 34059088
[TBL] [Abstract][Full Text] [Related]
16. [Vaccination immunology in SARS-CoV-2].
Helweg-Larsen J; Benfield T
Ugeskr Laeger; 2021 Mar; 183(11):. PubMed ID: 33734074
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 vaccination and cancer immunotherapy: should they stick together?
Brest P; Mograbi B; Hofman P; Milano G
Br J Cancer; 2022 Jan; 126(1):1-3. PubMed ID: 34799696
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 pneumonia and immune-related pneumonitis: critical issues on differential diagnosis, potential interactions, and management.
Russano M; Citarella F; Napolitano A; Dell'Aquila E; Cortellini A; Pantano F; Vincenzi B; Tonini G; Santini D
Expert Opin Biol Ther; 2020 Sep; 20(9):959-964. PubMed ID: 32588674
[TBL] [Abstract][Full Text] [Related]
19. Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors.
Switzer B; Haanen J; Lorigan PC; Puzanov I; Turajlic S
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34272309
[TBL] [Abstract][Full Text] [Related]
20. Impact of chemotherapy and immunotherapy on the composition and function of immune cells in COVID-19 convalescent with gynecological tumors.
Qin T; Guo E; Lu F; Fu Y; Liu S; Xiao R; Wu X; Liu C; He C; Wang Z; Qin X; Hu D; You L; Li F; Li X; Huang X; Ma D; Xu X; Yang B; Fan J
Aging (Albany NY); 2021 Dec; 13(23):24943-24962. PubMed ID: 34862879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
